Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces the appointment of Professor Pierre Corvol as Chairman of its Scientific Advisory Board.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2014/07/QGC_CP_PRESIDENT_Scientific_Comitee_08072014_UK.pdf” target=”_blank” title=”Télécharger le pdf” size=”small” color=”red”]
